Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Nabil Seery, Vivien Li, Ai-Lan Nguyen, Izanne Roos, Katherine A Buzzard, Roberts Atvars, Nicola Taylor, Kelsey Tunnell, John Carey, Chris Dwyer, Hasini Fernandoa Lisa Taylor, Josephine Baker, Mark P Marriott, Trevor J Kilpatrick, Tomas Kalincik, Mastura Monif (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 20, 2020 Category: Neurology Source Type: research

Smartphone based behavioral therapy for pain in multiple sclerosis (MS) patients: A feasibility acceptability randomized controlled study for the treatment of comorbid migraine and ms pain
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Mia T. Minen, Kathryn B. Schaubhut, Kaitlyn Morio (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 19, 2020 Category: Neurology Source Type: research

Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter study
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Alon Kalron, Rainer Ehling, Ilse Baert, Tori Smedal, Kamila Rasova, Adnan Heric-Mansrud, Iratxe Elorriage, Una Nedeljkovic, Andrea Tachino, Leszek Gargul, Klaus Gusowski, Davide Cattaneo, Sophie Borgers, Jeffrey Hebert, Ulrik Dalgas, Peter Feys (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 17, 2020 Category: Neurology Source Type: research

Feasibility of improving dietary quality using a telehealth lifestyle intervention for adults with multiple sclerosis
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Brooks C. Wingo, John R. Rinker, Amy M. Goss, Kathryn Green, Victoria Wicks, Gary R. Cutter, Robert W. Motl (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 16, 2020 Category: Neurology Source Type: research

Off-label use of tocilizumab in neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases: A case-series
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): J. Rigal, G. Pugnet, J. Ciron, Z. Lépine, D. Biotti (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 16, 2020 Category: Neurology Source Type: research

Inflammatory colitis associated with Teriflunomide
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Neda Zarghami Esfahani, Gloria von Geldern, Meghan C Romba, Dhavan A Parikh, Annette Wundes (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 16, 2020 Category: Neurology Source Type: research

Efficacy and safety of azathioprine for neuromyelitis optica spectrum disorders: A meta-analysis of real-world studies
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Daohuang Luo, Ran Wei, Xin Tian, Chaoyang Chen, Lingyun Ma, Min Li, Xiu Dong, Enyao Zhang, Ying Zhou, Yimin Cui (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 14, 2020 Category: Neurology Source Type: research

Does obesity exacerbate brain lesion volume and atrophy in patients with multiple sclerosis?
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Rachel Galioto, Ophira Berenholz, Zhini Wang, Devon S. Conway, Sarah M. Planchon, Stephen M. Rao (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 14, 2020 Category: Neurology Source Type: research

Utilization of video oculography to quantify oculomotor dysfunction in anti-DPPX encephalitis: A case study
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Kyle Blackburn, Steven Vernino, Peter Sguigna (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 14, 2020 Category: Neurology Source Type: research

Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies?
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Elisabeth Maillart, Caroline Papeix, Catherine Lubetzki, Thomas Roux, Valérie Pourcher, Céline Louapre (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 10, 2020 Category: Neurology Source Type: research

Experimental mouse model of NMOSD produced by facilitated brain delivery of NMO-IgG by microbubble-enhanced low-frequency ultrasound in experimental allergic encephalomyelitis mice
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Jiaying Luo, Chong Xie, Wei Zhang, Yu Cai, Jie Ding, Yishu Wang, Yong Hao, Ying Zhang, Yangtai Guan (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 10, 2020 Category: Neurology Source Type: research

Prognostic value of odor identification impairment in multiple sclerosis: 10-Years follow-up
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Ana Martins da Silva, C. Torres, I. Ferreira, I. Moreira, R. Samões, A.P. Sousa, E. Santos, A. Teixeira-Pinto, S. Cavaco (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 10, 2020 Category: Neurology Source Type: research

Determinants of unemployment in multiple sclerosis (MS): The role of disease, person-specific factors, and engagement in positive health-related behaviors
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Dr. Lauren Strober (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 10, 2020 Category: Neurology Source Type: research

Favorable outcomes after COVID-19 infection in multiple sclerosis patients treated with cladribine tablets
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Dominic Jack, Axel Nolting, Andrew Galazka (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 10, 2020 Category: Neurology Source Type: research

Nordic walking for people with relapsing-remittent multiple sclerosis: A case series study.
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Iván Martínez-Lemos, Daniel Martínez-Aldao, Manuel Seijo-Martínez, Carlos Ayán (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 8, 2020 Category: Neurology Source Type: research

Lymphomatosis cerebri masquerading as the Marburg variant of multiple sclerosis
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Nasser AlOhaly, Nabeela Nathoo, Laura M. Schmitt, Jennifer A. McCombe (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 8, 2020 Category: Neurology Source Type: research

Differential diagnosis in acute inflammatory myelitis
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): M. Marrodan, M.A. Hernandez, A.A. Köhler, J. Correale (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 8, 2020 Category: Neurology Source Type: research

Brain MRI characteristics in neuromyelitis optica spectrum disorders: A large multi-center retrospective study in China
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Guanmei Cao, Yunyun Duan, Ningnannan Zhang, Jie Sun, Haiqing Li, Yuxin Li, Yongmei Li, Chun Zeng, Xuemei Han, Fuqing Zhou, Muhua Huang, Zhizheng Zhuo, Sven Haller, Yaou Liu (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 7, 2020 Category: Neurology Source Type: research

Pharmacotherapy in multiple sclerosis-induced cognitive impairment: A systematic review and meta-analysis
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Ali Motavalli, Alireza Majdi, Leila Hosseini, Mahnaz Talebi, Javad Mahmoudi, Seyed Hojjat Hosseini, Saeed Sadigh-Eteghad (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 5, 2020 Category: Neurology Source Type: research

Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: A case report
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Naomi S. de Ruijter, Gerrit Kramer, Rob A.R. Gons, Gerald J.D. Hengstman (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 5, 2020 Category: Neurology Source Type: research

Urinary tract infection in patients with multiple sclerosis: An overview
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Washigton Luiz Gomes de Medeiros Junior, Caio Cesar Demore, Larissa Peres Mazaro, Matheus Fellipe Nascimento de Souza, Laura Fiuza Parolin, Luiz Henrique Melo, Claudio Rogerio Werka Junior, Marcus Vinicius Magno Gonçalves (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 4, 2020 Category: Neurology Source Type: research

Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Mohammad Ali Sahraian, Amirreza Azimi, Samira Navardi, Sara Ala, Abdorreza Naser Moghadasi (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 4, 2020 Category: Neurology Source Type: research

Occurrence of primary progressive multiple sclerosis in a patient with argyria: Causality or coincidence?
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Immanuel P. Seitz, Markus C. Kowarik, Jennifer Sartor-Pfeiffer, Ulf Ziemann, Helmut Wilhelm, Karl Ulrich Bartz-Schmidt (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 4, 2020 Category: Neurology Source Type: research

Normal antibody response after COVID-19 during treatment with cladribine
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Elisabeth G. Celius (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 2, 2020 Category: Neurology Source Type: research

High effector-memory CD8+ T-cell levels correlate with high PML risk in natalizumab-treated patients
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Asma Beldi-Ferchiou, Abir Wahab, Matthieu Duchmann, Jérôme Hodel, Ivania Patry, Marie-Hélène Delfau-Larue, Valérie Molinier-Frenkel, Alain Créange (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 2, 2020 Category: Neurology Source Type: research

Distinguishing physiological versus pathological serum NfL levels in multiple sclerosis will require serial measurements
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): I. Smets, S. Reyes, G. Giovannoni (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - September 2, 2020 Category: Neurology Source Type: research

Acute disseminated encephalomyelitis following Tdap vaccination and bacterial meningoencephalitis
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): J. Niederschweiberer, M. Lauerer, K. Schweyer, C. Maegerlein, F. Liesche, S. Hofer, A. Berthele, P. Lingor (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 30, 2020 Category: Neurology Source Type: research

Reasons for switching to fingolimod in patients relapsing-remitting multiple sclerosis in France: the ESGILE study
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Ayman Tourbah, Caroline Papeix, Patricia Tourniaire, Karin Rerat, Mohamed Meite, Barbara Durand, Fabienne Lamy, Isabelle Chouette, Claude Mekies, ESGILE Study Group (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 27, 2020 Category: Neurology Source Type: research

Coexistent MOG, NMDAR, CASPR2 antibody positivity: Triumph over the triumvirate
Publication date: Available online 25 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Ajith Cherian, K.P Divya, Sarath Chandra Shetty, Sudheeran Kannoth, Bejoy Thomas (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 27, 2020 Category: Neurology Source Type: research

Paediatric onset of multiple sclerosis: analysis of chemokine and cytokine levels in the context of the early clinical course
Publication date: Available online 24 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): H. Nohejlova, J. Kayserova, V. Capek, T. Toman, P. Krsek, Z. Liba (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 24, 2020 Category: Neurology Source Type: research

Changes in Th17 cells frequency and function after ozone therapy used to treat multiple sclerosis patients
Publication date: Available online 24 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Morteza Izadi, Safa Tahmasebi, Inna Pustokhina, Alexei Valerievich Yumashev, Tayyebeh Lakzaei, Akbar Ghorbani Alvanegh, Leila Roshangar, Mehdi Dadashpour, Mehdi Yousefi, Majid Ahmadi (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 24, 2020 Category: Neurology Source Type: research

NFL and CXCL13 may reveal disease activity in clinically and radiologically stable MS
Publication date: Available online 22 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): L. Novakova, M. Axelsson, C. Malmeström, H. Zetterberg, K. Blennow, A. Svenningsson, J. Lycke (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 23, 2020 Category: Neurology Source Type: research

Benefit-harm balance of fingolimod in patients with MS: a modelling study based on FREEDOMS
Publication date: Available online 23 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Alessandra Spanu, Hélène E. Aschmann, Jürg Kesselring, Milo A. Puhan (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 23, 2020 Category: Neurology Source Type: research

Multiple sclerosis in a young woman with sickle cell disease
Publication date: October 2020Source: Multiple Sclerosis and Related Disorders, Volume 45Author(s): Kate Kerpen, Ayanna Baptiste, Anusha K. Yeshokumar (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 23, 2020 Category: Neurology Source Type: research

Prediction of long-term disability in Chinese patients with multiple sclerosis: a prospective cohort study
Publication date: Available online 22 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Yao Zhang, Yan Xu, Tao Xu, Hexiang Yin, Yicheng Zhu, Bin Peng, Liying Cui (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 22, 2020 Category: Neurology Source Type: research

Atypical Clinical and Radiological Presentation of Multiple Sclerosis: A Case Report
Publication date: Available online 22 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Rina Ghorpade, Ans Ahamad, Jennifer Bolyard (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 22, 2020 Category: Neurology Source Type: research

Elevated serum interleukin-39 levels in patients with neuromyelitis optica spectrum disorders correlated with disease severity
Publication date: Available online 30 July 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Meng-Ge Yang, Suyan Tian, Qingxiang Zhang, Jinming Han, Caiyun Liu, Yang Zhou, Jie Zhu, Tao Jin (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 22, 2020 Category: Neurology Source Type: research

Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study
Publication date: Available online 1 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Aaron E. Miller, Tomas P. Olsson, Jerry S. Wolinsky, Giancarlo Comi, Ludwig Kappos, Xueqiang Hu, Xianhao Xu, Alex L. Lublin, Philippe Truffinet, Jeffrey Chavin, Jean-Luc Delhay, Myriam Benamor, Annie Purvis, Mark S. Freedman, TOWER investigators (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 22, 2020 Category: Neurology Source Type: research

Is neuromyelitis optica without AQP4-IgG a T-cell mediated disease? Insights from checkpoint inhibitor immune-related adverse events
Publication date: Available online 15 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Salam Nasralla, Hesham Abboud (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 22, 2020 Category: Neurology Source Type: research

A Case Report with Tuberculous Meningitis During Fingolimod Treatment
Publication date: Available online 15 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Mesrure Köseoğlu, Rabia Gökçen Gözübatık Çelik, Murat Kürtüncü (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 22, 2020 Category: Neurology Source Type: research

Safety Results of Administering Ocrelizumab per a Shorter Infusion Protocol in Patients With Primary Progressive and Relapsing Multiple Sclerosis
Publication date: Available online 18 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Timothy L. Vollmer, Jeffrey A. Cohen, Enrique Alvarez, Kavita V. Nair, Aaron Boster, Joshua Katz, Gabriel Pardo, Jinglan Pei, Pranil Raut, Sharmin Merchant, Elizabeth MacLean, Ashish Pradhan, Brandon Moss (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 22, 2020 Category: Neurology Source Type: research

Assessing the susceptibility to acute respiratory illness COVID-19-related in a cohort of multiple sclerosis patients
Publication date: Available online 19 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Vittorio Mantero, Lucia Abate, Roberto Balgera, Paola Basilico, Andrea Salmaggi, Christian Cordano (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 22, 2020 Category: Neurology Source Type: research

Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis with Considerable White Blood Cell Elevation in Cerebrospinal Fluid
Publication date: Available online 20 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Corey J. Miller, Jeffrey Bennett, Michael Lee (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 22, 2020 Category: Neurology Source Type: research

Would it be recommended treating multiple sclerosis relapses with high dose oral instead intravenous steroids during the COVID-19 pandemic? Yes.
Publication date: Available online 20 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Constanza Segamarchi, Berenice Silva, Patricia Saidon, Orlando Garcea, Ricardo Alonso (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 22, 2020 Category: Neurology Source Type: research

Resolution of myelin oligodendrocyte glycoprotein (MOG)-IgG optic neuritis without treatment
Publication date: Available online 20 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Amir R. Vosoughi, Jonathan A. Micieli (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 22, 2020 Category: Neurology Source Type: research

Application of the 2015 neuromyelitis optica spectrum disorders diagnostic criteria in a cohort of Chinese patients
Publication date: Available online 21 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Mianwang He, Lei Wu, Dehui Huang, Shengyuan Yu (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 22, 2020 Category: Neurology Source Type: research

CLINICAL course of acute disseminated encephalomyelitis in adults from Rio de Janeiro: Retrospective study of 23 cases and literature review
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Marcell Pourbaix Morisson Guimarães, Anna Christiany Brandão Nascimento, Regina Maria Papais Alvarenga (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 22, 2020 Category: Neurology Source Type: research

Localised multiple sclerosis-like disease after irradiation of the cervicothoracic spinal cord
Publication date: October 2020Source: Multiple Sclerosis and Related Disorders, Volume 45Author(s): Christian Eggers, Verena Kopatz, Wolfgang Dörr, Hans Lassmann, Hans Geinitz (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 20, 2020 Category: Neurology Source Type: research

Severe anti-GFAP meningo-encephalomyelitis following viral infection
Publication date: October 2020Source: Multiple Sclerosis and Related Disorders, Volume 45Author(s): Nahéma Issa, Clément Martin, Cécile Dulau, Fabrice Camou (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 19, 2020 Category: Neurology Source Type: research

Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice
Publication date: October 2020Source: Multiple Sclerosis and Related Disorders, Volume 45Author(s): Marcello De Angelis, Maria Petracca, Roberta Lanzillo, Vincenzo Brescia Morra, Marcello Moccia (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - August 19, 2020 Category: Neurology Source Type: research